At-Home Testing Company Cor Crowdfunding for Commercialization

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies At-home testing company Cor (San Francisco) has taken to online crowdfunding to commercialize its blood chemistry device. As of … [Read more...]


At Lab Revolution, a Call for Changing the ‘Rules of Engagement’

By Stephanie Murg, Managing Director, G2 Intelligence Gone are the days of isolated entities and closed systems within the American healthcare industry. And as once discrete services come to extend … [Read more...]


Sequenom to Petition U.S. Supreme Court to Regain MaterniT21 Test Patent

With its sales and margins suffering unrelenting pressure, the beleaguered molecular testing firm Sequenom has decided to petition the United States Supreme Court in an attempt to regain a patent for … [Read more...]


A Slow But Growing Push for Greener Laboratories

Ilyssa Gordon, M.D., is a gastrointestinal pathologist by profession and an environmentalist by passion. When she joined the staff of the Cleveland Clinic four years ago, she decided to delve into … [Read more...]


As Theranos Tries to Fix Up California Lab, Reports Surface It May Have Performed Inaccurate Blood Clotting Tests

As startup laboratory Theranos continues to struggle through its regulatory and compliance growing pains, it appears to be using the fingers of one corporate hand to keep better tabs on its … [Read more...]


Proteomics, Metabolomics Could Stratify Women at Risk for Common, But Serious Pregnancy Conditions

Noninvasive prenatal testing (NIPT) for trisomies has dominated the obstetrics-related diagnostic headlines and masked the lack of development for diagnostics for other pregnancy-related conditions. … [Read more...]


Genomic Testing Shows Promise for Metastatic Prostate Cancer

By Stephanie Murg, Managing Director, G2 Intelligence On the heels of last week's White House Precision Medicine Summit, new research findings suggest that a personalized approach can benefit … [Read more...]